Skip to content

Comparison of postoperative Analgesia given Sufentanil or Tegileridine in Laparoscopic Appendectomy, a prospective, randomized, controlled, blinded study

Comparison of postoperative Analgesia given Sufentanil or Tegileridine in Laparoscopic Appendectomy, a prospective, randomized, controlled, blinded study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112141
Enrollment
Unknown
Registered
2025-11-11
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia After Laparoscopic Appendectomy

Interventions

Sponsors

Puyang Oil Field General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA class I-II; 2. Age 18–65 years; 3. Body weight 50–90 kg and BMI 18–30 kg/m^2

Exclusion criteria

Exclusion criteria: 1. Chronic pain history; 2. Opioid abuse history; 3. Bowel obstruction; 4. History of anxiety or depression; 5. Inability to communicate normally; 6. Participation in another clinical trial; 7. Patient or family refusal

Design outcomes

Primary

MeasureTime frame
The incidence of moderate to severe pain 24 hours after the operation;

Secondary

MeasureTime frame
Recovery time from anesthesia;Length of stay in PACU;The incidence of emergency agitation;Pain score arriving at PACU;Pain score discharging from PACU;Pain scores at 6, 12, 48 hours after the operation;Opioid consumption in morphine milligram equivalents (MME) postoperative 48 hours;The first anal exhaust time;The incidence of PONV;The incidence of urinary retention;The incidence of pain postoperative 3 months;

Countries

China

Contacts

Public ContactYue Caibao

Puyang Oil Field General Hospital

yuecb1987@163.com+86 150 3931 5428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026